)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Dogwood Therapeutics
Dogwood Therapeutics (DWTX) investor relations material
Dogwood Therapeutics Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary8 Sep, 2026
Corporate overview and leadership
Headquarters in Atlanta, GA, listed on Nasdaq with 33.99 million shares outstanding and $13.2 million in cash as of March 31, 2026.
Executive team has a proven track record developing blockbuster pain medicines such as Celebrex, Lyrica, Savella, and Cimzia.
Analyst coverage includes H.C. Wainwright and Maxim Group.
Unmet medical need and market opportunity
Over 3 million US patients suffer from chemotherapy-induced neuropathic pain (CINP), with 7.5 million experiencing painful neuropathy.
CINP market across US, EU4/UK, and Japan is valued at $1B, projected to reach $3B by 2036.
No FDA-approved treatments for CINP; current therapies include SNRIs, opioids, and tricyclic antidepressants.
Lead asset: Halneuron® (Tetrodotoxin, TTX)
Halneuron is a voltage-gated sodium channel blocker, specifically targeting NaV1.7, critical for pain signaling.
Demonstrated statistically significant and durable pain reduction in cancer and chemotherapy-related pain studies.
Administered as a subcutaneous injection, with no central nervous system effects.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Dogwood Therapeutics
- A novel, scalable NaV1.7 inhibitor shows durable efficacy for chemotherapy-induced neuropathic pain.DWTX
KOL event - Q2 2026 net loss reached $11.5M as CINP trial nears completion; cash runway into Q4 2026.DWTXQ2 2026
- Halneuron delivers significant, durable pain relief for cancer patients with a strong safety profile.DWTXCorporate presentation
- Halneuron® and SP16 advance as first-in-class non-opioid pain therapies targeting major unmet needs.DWTXCorporate presentation
- Pipeline advances, narrowed net loss, and cash runway into Q4 2026; more funding needed.DWTXQ1 2026
- Halneuron® delivers significant pain relief in CINP, with pivotal data expected Fall 2026.DWTXCorporate presentation
- Stockholders will vote on directors, auditor, share increase, and executive pay, with Board support.DWTXProxy filing
- Stockholders will vote on director elections, auditor ratification, share increases, and executive pay.DWTXProxy filing
- Halneuron and SP16 progress in clinical trials for chemotherapy-induced neuropathy and pain.DWTXStudy Update
Next Dogwood Therapeutics earnings date
Q3 202610 Nov, 2026
Dogwood Therapeutics
Next Dogwood Therapeutics earnings date
Q3 202610 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage